SAN DIEGO, CA; USA I January 21, 2025 I Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback